MERIDIAN BIOSCIENCE INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Meridian Bioscience Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q4 2022.
  • Meridian Bioscience Inc Operating Income (Loss) for the quarter ending December 31, 2022 was -$28.1M, a 239% decline year-over-year.
  • Meridian Bioscience Inc Operating Income (Loss) for the twelve months ending December 31, 2022 was $5.99M, a 92.4% decline year-over-year.
  • Meridian Bioscience Inc annual Operating Income (Loss) for 2022 was $54.4M, a 41.5% decline from 2021.
  • Meridian Bioscience Inc annual Operating Income (Loss) for 2021 was $93M, a 51.7% increase from 2020.
  • Meridian Bioscience Inc annual Operating Income (Loss) for 2020 was $61.3M, a 87.5% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $5.99M -$28.1M -$48.4M -239% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $54.4M $4.65M -$3.84M -45.2% Jul 1, 2022 Sep 30, 2022 10-K 2022-11-22
Q2 2022 $58.2M -$6.68M -$22.4M -143% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $80.6M $36.1M +$1.94M +5.67% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $78.7M $20.3M -$14.4M -41.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 $93M $8.49M -$985K -10.4% Jul 1, 2021 Sep 30, 2021 10-K 2022-11-22
Q2 2021 $94M $15.7M -$19M -54.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $113M $34.2M +$22.4M +190% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $90.6M $34.7M +$29.3M +543% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-04
Q3 2020 $61.3M $9.47M +$3.63M +62% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-22
Q2 2020 $57.7M $34.7M +$28.2M +436% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $29.5M $11.8M +$1.96M +19.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $27.5M $5.39M -$5.16M -48.9% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-05
Q3 2019 $32.7M $5.85M -$1.26M -17.7% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 $34M $6.46M -$2.27M -26% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $36.2M $9.84M +$2.16M +28.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $34.1M $10.6M +$2.49M +30.9% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-07
Q3 2018 $31.6M $7.11M -$1.7M -19.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 $33.3M $8.74M +$4.43M +103% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $28.9M $7.68M -$6.51M -45.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $35.4M $8.06M -$2.02M -20.1% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 $37.4M $8.81M -$88K -0.99% Jul 1, 2017 Sep 30, 2017 10-K 2019-11-26
Q2 2017 $37.5M $4.3M -$9.44M -68.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $46.9M $14.2M -$970K -6.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $47.9M $10.1M -$3.5M -25.8% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 $51.4M $8.9M -$4.37M -32.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-11-29
Q2 2016 $55.7M $13.7M -$657K -4.56% Mar 25, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $56.4M $15.2M -$576K -3.66% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $57M $13.6M +$917K +7.24% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $56.1M $13.3M +$1.29M +10.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-11-29
Q2 2015 $54.8M $14.4M +$1.27M +9.64% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $53.5M $15.7M +$66K +0.42% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $53.4M $12.7M +$1.04M +8.97% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $52.4M $12M -$1.3M -9.82% Jul 1, 2014 Sep 30, 2014 10-K 2016-11-29
Q2 2014 $53.7M $13.1M -$2.57M -16.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $56.3M $15.7M +$413K +2.71% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $55.8M $11.6M -$1.47M -11.2% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $57.3M $13.3M +$1.22M +10.1% Jul 1, 2013 Sep 30, 2013 10-K 2015-11-30
Q2 2013 $56.1M $15.7M +$3.09M +24.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $53M $15.3M +$426K +2.87% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $52.6M $13.1M +$3.29M +33.5% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-10
Q3 2012 $49.3M $12.1M +$2.2M +22.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-12-01
Q2 2012 $47.1M $12.6M +$2.48M +24.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $44.6M $14.8M +$3.87M +35.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $40.7M $9.81M +$715K +7.87% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-11
Q3 2011 $40M $9.85M Jul 1, 2011 Sep 30, 2011 10-K 2013-11-29
Q2 2011 $10.1M +$355K +3.63% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $11M +$1.84M +20.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $9.09M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q2 2010 $9.78M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
Q1 2010 $9.13M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.